ArticleActa parasitologica2025
Assessment of the Therapeutic Role of Allium tuncelianum Extract in Rats Infected with Blastocystis Subtype 3.
Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeBlastocystis is one of the most prevalent intestinal protists detected in humans and animals worldwide, and its role in human health and disease has become an increasingly debated topic in parasitology. The study investigated the therapeutic potential of Allium tuncelianum extract, an endemic plant of Turkey, as an alternative treatment for Blastocystis ST3 infections.
methodsThe experimental animals were infected with Blastocystis ST3. The animals were divided into six groups: healthy control (G1), infected control (G2), infected Allium tuncelianum extract treatment (G3a, G3b, and G3c) and infected Metronidazole treatment (G4). Microscopic examination and qPCR methods were used to determine Blastocystis load in fecal samples.
resultsThe G3c group (250 mg/kg/day Allium tuncelianum) complete (100.0%) microscopic clearance of Blastocystis load in fecal samples was achieved by day 12th, whereas the Metronidazole group (G4), showed only an 84.1% reduction. Moreover, qPCR results revealed lower Blastocystis loads in groups G3c and G3b compared to Metronidazole. A statistically significant decrease in fecal Blastocystis load was observed in all treated groups compared to the infected group (G2) (p < 0.0001). Blastocystis load in fecal sample reduction exhibited a dose-dependent pattern across all Allium tuncelianum treatment groups, confirming the dose-dependent therapeutic effect of the extract. Allium tuncelianum extract, especially at higher doses, may serve as a natural, effective, and safer alternative or supplement to Metronidazole in the management of Blastocystis infection.
conclusionThis study demonstrated that Allium tuncelianum extract exhibited superior therapeutic efficacy against Blastocystis ST3 compared to Metronidazole. The findings suggest that regular dietary consumption of Allium tuncelianum could represent a promising natural alternative for managing Blastocystis infections.
Indexed as
Identifiers
40903612What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.